April 4, 2017 · STOCK Act disclosure
Representative John K. Delaney (Democrat-MD) bought SAGE Therapeutics Holdings, a stock transaction, valued at $1,001 - $15,000. The trade took place on April 4, 2017 and was disclosed on January 27, 2017 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.